También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approach.
Radiation oncology (London, England)·2024
Same author
Comparative assessment of radiation therapy-induced vasculitis using [<sup>18</sup>F]FDG-PET/CT in patients with non-small cell lung cancer treated with proton versus photon radiotherapy.
European journal of nuclear medicine and molecular imaging·2023
Same author
CT for detection of malignant posterior intercostal lymph nodes in patients undergoing pre-operative staging for malignant pleural mesothelioma.
Lung cancer (Amsterdam, Netherlands)·2020
Same author
Safety of thoracic radiotherapy in patients with prior immune-related adverse events from immune checkpoint inhibitors.
Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author
Integrative Wellness for Patients Receiving Proton Therapy: A Patient-Centered Collaboration.
Journal of alternative and complementary medicine (New York, N.Y.)·2018
Same author
Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma.
International journal of radiation oncology, biology, physics·2017
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026


